UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063718
Receipt number R000072915
Scientific Title A Retrospective Observational Study of the Association Between Changes in Measured Multi-Hair Follicular Unit Percentage and Treatment Response Across Different Treatment Strategies for Male Androgenetic Alopecia
Date of disclosure of the study information 2026/11/22
Last modified on 2026/11/21 11:54:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study of the association between changes in measured MFU% (multi-hair follicular unit rate) and treatment response across different treatment strategies for male androgenetic alopecia

Acronym

A Retrospective Observational Study of the Relationship Between Changes in Hair Characteristics and Treatment Response in Different Treatments for Male Androgenetic Alopecia

Scientific Title

A Retrospective Observational Study of the Association Between Changes in Measured Multi-Hair Follicular Unit Percentage and Treatment Response Across Different Treatment Strategies for Male Androgenetic Alopecia

Scientific Title:Acronym

MFU-Response Study

Region

Japan


Condition

Condition

Male androgenetic alopecia

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association between treatment response (responders vs. non-responders) at 12 months after initial treatment and the change in measured multi-hair follicular unit percentage from baseline to 12 months in patients with male androgenetic alopecia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The difference in the change in measured multi-hair follicular unit percentage between the responder and non-responder groups in the pooled pre-analysis population comprising all five treatment groups.

Key secondary outcomes

1) The proportions of patients classified as responders and non-responders in each treatment group.
2) Changes in trichoscopic parameters, including maximum hair diameter, terminal hair percentage, and hair density, in each treatment group.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male

Key inclusion criteria

Patients must meet all of the following criteria to be eligible for inclusion in this study:
1. Male patients diagnosed with male androgenetic alopecia.
2. Patients who can be classified into one of the five treatment groups defined in this study: SHED-CM monotherapy, needle radiofrequency (RF) monotherapy, alternating SHED-CM and needle RF therapy, same-day combined SHED-CM and needle RF therapy, or dutasteride monotherapy.
3. Availability of clinical information and trichoscopic images at baseline (T0), before treatment initiation.
4. Availability of trichoscopic images at approximately 12 months after treatment initiation (T12).
5. Availability of evaluable multi-hair follicular unit percentage (MFU%) and QTES measurements from images obtained at both T0 and T12.

Key exclusion criteria

Patients meeting any of the following criteria will be excluded from the study:
1. Patients with alopecia other than male androgenetic alopecia (MAGA), or whose hair loss is considered primarily attributable to another disease.
2. Patients with concomitant alopecia areata, scarring alopecia, or other forms of alopecia that may affect trichoscopic assessment.
3. Patients with missing or inadequate-quality trichoscopic images at T0 or T12, preventing reliable assessment of MFU% or QTES.
4. Patients with insufficient medical records to confirm the treatment received, treatment initiation date, or assessment time points.
5. Patients who cannot be classified into any of the five treatment groups defined in this study.
6. Patients who received additional major MAGA treatments during the observation period, making it difficult to assess the association between changes in MFU% and the treatment strategy.

Target sample size

125


Research contact person

Name of lead principal investigator

1st name Tomoko
Middle name
Last name Kamishima

Organization

Tokyo Midtown Skin/Aesthetic Clinic Noage

Division name

Department of Dermatology

Zip code

107-6206

Address

Midtown Tower 6F 9-7-1 Akasaka Minato-ku Tokyo Japan

TEL

0354130082

Email

t-kamishima@tokyomidtown-mc.jp


Public contact

Name of contact person

1st name Asami
Middle name
Last name Ito

Organization

Advanced Medical Care Inc.

Division name

Noage Dental Division

Zip code

107-6206

Address

Midtown Tower 6F 9-7-1 Akasaka Minatoku Tokyo Japan

TEL

0354130082

Homepage URL


Email

a-ito@amcare.co.jp


Sponsor or person

Institute

Tokyo midtown Center for Advanced Medical Science and Technology

Institute

Department

Personal name



Funding Source

Organization

Tokyo midtown Center for Advanced Medical Science and Technology

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Midtown Medical Center Ethical Review Board

Address

Midtown Tower 6F 9-7-1 Akasaka Minatoku Tokyo Japan

Tel

0332312062

Email

k-aramaki@amcare.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京ミッドタウン皮膚科形成外科クリニック・ノアージュ


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 01 Month 01 Day

Date of IRB

2026 Year 11 Month 12 Day

Anticipated trial start date

2021 Year 01 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Assessment Time Points

Each patient will be evaluated at two time points: before treatment initiation (T0) and approximately 12 months after treatment initiation (T12).

Definition of T0

Trichoscopic images and clinical information obtained as part of routine clinical practice within 0 to 2 months before the treatment initiation date.

Definition of T12

Trichoscopic images and clinical information obtained as part of routine clinical practice within 10 to 14 months after treatment initiation.

T0 Eligibility Period

January 1, 2021, to March 31, 2027.

Final Deadline for T12 Data Collection

March 31, 2028.

Assessment Methods
Trichoscopic images and clinical information obtained at each time point (T0 and T12) will be used for assessment. Data obtained at 3, 6, and 9 months will not be included in the assessments for this study.


Management information

Registered date

2026 Year 11 Month 21 Day

Last modified on

2026 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072915